<PAGE>
/------------------------------/
/ OMB APPROVAL /
/------------------------------/
/ OMB Number: 3235-0287 /
/ Expires: September 30, 1998 /
/ Estimated average burden /
/ hours per response...... 0.5 /
/------------------------------/
+--------+
| FORM 4 | U.S. SECURITIES AND EXCHANGE COMMISSION
+--------+ WASHINGTON, D.C. 20549
[_] Check this box if
no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
to Section 16.
Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities
obligations may Exchange Act of 1934, Section 17(a) of the
continue. See Public Utility Holding Company Act of 1935 or
Instruction 1(b). Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Kirk Randal J.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
The Govenor Tyler
1902 Downey Street
--------------------------------------------------------------------------------
(Street)
Radford Virginia 24141
--------------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol Novitron International, Inc.
(NASDAQ-"NOVI")
------------------------------------
3. I.R.S. or Social Security Number of Reporting Person (Voluntary)
--------------
4. Statement for Month/Year December 2000
---------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
---------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
X
___ Director ___ Officer --- 10% Owner ___ Other
(give title below) (specify below)
----------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X
---- Form filed by One Reporting Person
____ Form filed by More than One Reporting Person
Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of
of action action or Disposed of (D) Securities Form: Indirect
Security Date Code (Instr. 3, 4 and 5) Beneficially Direct (D) Beneficial
(Instr. 3) (Month/ (Instr. 8) Owned at or Indirect Ownership
Day/ ----------------------------------------------- End of Month (I)
Year)
Code V Amount (A) or (D) Price (Instr. 3 and 4) (Instr. 4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock, $.01
par value per share 12/4/00 P 200 A $1.94
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, $.01
par value per share 12/8/00 p 200 A $1.98 239,269(1) D
------------------------------------------------------------------------------------------------------------------------------------
53,680(1) I By Kirkfield
------------------------------------------------------------------------------------------------------------------------------------
99,801(1) I By RJK
------------------------------------------------------------------------------------------------------------------------------------
9,283(1) I By Zhong Mei
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
<PAGE>
FORM 4 (continued )
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv-
Security (Instr. 3) sion or action tion Code ative Securities
Exercise Date (Instr. 8) Acquired (A) or
Price of (Month/ Disposed of (D)
Deriv- Day/ (Instr. 3, 4, and 5)
ative Year)
Security
---------------------------------------------------
Code V (A) (D)
-----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
None.
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------
</TABLE>
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Nature
cisable and Underlying Securities of of Deriv- ship of In-
Expiration (Instr. 3 and 4) Deriv- ative Form direct
Date ative Secur- of De- Bene-
(Month/Day/ Secur- ities rivative ficial
Year) ity Bene- Security, Owner-
(Instr. ficially Direct ship
-------------------------------------------- 5) Owned (D) or (Instr.
Date Expira- Amount or at End Indirect 4)
Exer- tion Title Number of of (I)
cisable Date Shares Month
(Instr. 4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) On December 31, 2000, Clinical Chemistry Holdings, Inc. ("CCH"), a
corporation controlled by Randal J. Kirk, sold 398,133 shares (all of which
were previously reported as being indirectly beneficially owned by Randal J.
Kirk) to the following persons: Mr. Kirk (239,269 shares), Kirkfield, L.L.C.
("Kirkfield") (49,780 shares), RJK, L.L.C. ("RJK") (99,801 shares) and Zhong
Mei, L.L.C. ("Zhong Mei") (9,283 shares). Mr. Kirk controls each of
Kirkfield, RJK and Zhong Mei. Kirkfield, RJK and Zhong Mei directly
beneficially own an aggregate of 162,764 shares (158,864 shares purchased
from CCH and 3,900 shares already directly beneficially owned by Kirkfield),
which shares may be deemed to be indirectly beneficially owned (as defined
under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as
amended) by Mr. Kirk.
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number. SEC 1474 (7-96)
/s/ Randal J. Kirk 1/8/01
----------------------------- -----------------
** Randal J. Kirk Date
